Geoff Meacham
Stock Analyst at B of A Securities
(4.04)
# 577
Out of 4,996 analysts
258
Total ratings
58.02%
Success rate
9.38%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNA Avidity Biosciences | Maintains: Buy | $56 → $65 | $42.95 | +51.34% | 7 | Sep 15, 2025 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $10 → $14 | $14.52 | -3.58% | 3 | Aug 28, 2025 | |
| VIR Vir Biotechnology | Upgrades: Buy | $12 → $14 | $5.49 | +155.01% | 3 | Aug 27, 2025 | |
| ABOS Acumen Pharmaceuticals | Maintains: Buy | $10 → $9 | $1.42 | +533.80% | 5 | Aug 25, 2025 | |
| AMGN Amgen | Maintains: Neutral | $305 → $310 | $272.98 | +13.56% | 13 | Aug 6, 2025 | |
| BIIB Biogen | Maintains: Neutral | $125 → $135 | $137.37 | -1.73% | 15 | Aug 1, 2025 | |
| PTCT PTC Therapeutics | Maintains: Neutral | $40 → $50 | $58.99 | -15.24% | 9 | Jul 28, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $79 → $78 | $61.67 | +26.48% | 3 | Jul 22, 2025 | |
| RPRX Royalty Pharma | Maintains: Buy | $40 → $42 | $35.04 | +19.86% | 3 | Jul 22, 2025 | |
| BBIO BridgeBio Pharma | Maintains: Buy | $50 → $54 | $50.05 | +7.89% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $72 | $67.42 | +6.79% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $28.50 | +47.37% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $79.69 | +38.03% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $6 | $8.55 | -29.82% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $650 | $563.90 | +15.27% | 22 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $210 → $205 | $220.61 | -7.08% | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $47 → $44 | $56.25 | -21.78% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $140 | $98.08 | +42.74% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $7 → $1 | $1.74 | -42.53% | 3 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $40 | $24.49 | +63.33% | 10 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $36.49 | +9.62% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $38.21 | +148.63% | 2 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $14.70 | +70.07% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $103 | $53.85 | +91.27% | 3 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $2.70 | +48.15% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $112.10 | +11.51% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $575 | $385.74 | +49.07% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $724.54 | +51.82% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $120 → $20 | $12.83 | +55.88% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $12.97 | +139.01% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $78.56 | +84.57% | 6 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $179.71 | -5.40% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $48 | $23.23 | +106.63% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $44.12 | +35.99% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $5.37 | +48.98% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $0.48 | +3,441.67% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $45 | $23.76 | +89.39% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $2.48 | +867.74% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $4.46 | -10.31% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $2.08 | +1,246.15% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $0.51 | +6,578.45% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $2.65 | +1,220.75% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $4.41 | +11,804.76% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $1.48 | +2,737.84% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $8.19 | +144.35% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.66 | +2,912.05% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $4.84 | +85.95% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $9.65 | +521.76% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7 | $3.45 | +102.90% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $16.60 | +38.55% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $82.70 | -0.85% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $432.66 | -78.04% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $9.16 | +773.36% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $142.00 | -4.93% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $9.41 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $1.39 | +1,338.85% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $15.00 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $446.40 | -64.61% | 5 | Nov 8, 2017 |
Avidity Biosciences
Sep 15, 2025
Maintains: Buy
Price Target: $56 → $65
Current: $42.95
Upside: +51.34%
Amylyx Pharmaceuticals
Aug 28, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $14.52
Upside: -3.58%
Vir Biotechnology
Aug 27, 2025
Upgrades: Buy
Price Target: $12 → $14
Current: $5.49
Upside: +155.01%
Acumen Pharmaceuticals
Aug 25, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $1.42
Upside: +533.80%
Amgen
Aug 6, 2025
Maintains: Neutral
Price Target: $305 → $310
Current: $272.98
Upside: +13.56%
Biogen
Aug 1, 2025
Maintains: Neutral
Price Target: $125 → $135
Current: $137.37
Upside: -1.73%
PTC Therapeutics
Jul 28, 2025
Maintains: Neutral
Price Target: $40 → $50
Current: $58.99
Upside: -15.24%
CRISPR Therapeutics AG
Jul 22, 2025
Maintains: Buy
Price Target: $79 → $78
Current: $61.67
Upside: +26.48%
Royalty Pharma
Jul 22, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $35.04
Upside: +19.86%
BridgeBio Pharma
Jun 25, 2025
Maintains: Buy
Price Target: $50 → $54
Current: $50.05
Upside: +7.89%
Jun 17, 2025
Initiates: Buy
Price Target: $72
Current: $67.42
Upside: +6.79%
Jun 17, 2025
Initiates: Buy
Price Target: $42
Current: $28.50
Upside: +47.37%
Jun 17, 2025
Initiates: Buy
Price Target: $110
Current: $79.69
Upside: +38.03%
Jun 17, 2025
Initiates: Sell
Price Target: $6
Current: $8.55
Upside: -29.82%
Jun 2, 2025
Maintains: Buy
Price Target: $700 → $650
Current: $563.90
Upside: +15.27%
May 14, 2025
Downgrades: Neutral
Price Target: $210 → $205
Current: $220.61
Upside: -7.08%
May 12, 2025
Maintains: Neutral
Price Target: $47 → $44
Current: $56.25
Upside: -21.78%
May 6, 2025
Maintains: Buy
Price Target: $145 → $140
Current: $98.08
Upside: +42.74%
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $1.74
Upside: -42.53%
Mar 13, 2025
Initiates: Neutral
Price Target: $40
Current: $24.49
Upside: +63.33%
Mar 13, 2025
Initiates: Buy
Price Target: $40
Current: $36.49
Upside: +9.62%
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $38.21
Upside: +148.63%
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $14.70
Upside: +70.07%
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $53.85
Upside: +91.27%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $2.70
Upside: +48.15%
Nov 14, 2024
Initiates: Buy
Price Target: $125
Current: $112.10
Upside: +11.51%
Nov 14, 2024
Initiates: Buy
Price Target: $575
Current: $385.74
Upside: +49.07%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $724.54
Upside: +51.82%
Oct 30, 2024
Downgrades: Underperform
Price Target: $120 → $20
Current: $12.83
Upside: +55.88%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $12.97
Upside: +139.01%
Jul 31, 2024
Maintains: Buy
Price Target: $150 → $145
Current: $78.56
Upside: +84.57%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $179.71
Upside: -5.40%
Mar 13, 2024
Maintains: Buy
Price Target: $24 → $48
Current: $23.23
Upside: +106.63%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $44.12
Upside: +35.99%
Aug 21, 2023
Maintains: Underperform
Price Target: $10 → $8
Current: $5.37
Upside: +48.98%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $0.48
Upside: +3,441.67%
Apr 21, 2023
Maintains: Neutral
Price Target: $50 → $45
Current: $23.76
Upside: +89.39%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $2.48
Upside: +867.74%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $4.46
Upside: -10.31%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $2.08
Upside: +1,246.15%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $0.51
Upside: +6,578.45%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $2.65
Upside: +1,220.75%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $4.41
Upside: +11,804.76%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $1.48
Upside: +2,737.84%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $8.19
Upside: +144.35%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.66
Upside: +2,912.05%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $4.84
Upside: +85.95%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $9.65
Upside: +521.76%
Jun 25, 2020
Initiates: Underperform
Price Target: $7
Current: $3.45
Upside: +102.90%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $16.60
Upside: +38.55%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $82.70
Upside: -0.85%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $432.66
Upside: -78.04%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $9.16
Upside: +773.36%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $142.00
Upside: -4.93%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $9.41
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $1.39
Upside: +1,338.85%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $15.00
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $446.40
Upside: -64.61%